Acrodermatitis chronica atrophicans affecting all four limbs in an 11-year-old girl

British Journal of Dermatology

Volumn 147, Issue 2, 2002, Pages 375-378

  Brzonova, I ^a,b   Wollenberg, A ^b   Prinz, J C ^b  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Acrodermatitis chronica atrophicans; Childhood

Indexed keywords

ACRODERMATITIS; ACRODERMATITIS CHRONICA ATROPHICANS; AGE; ARTICLE; BACTERIAL INFECTION; BORRELIA BURGDORFERI; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; LIMB DISEASE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY; SKIN DISEASE; TICK BORNE DISEASE; TRUNK;

ACRODERMATITIS; ANTIBODIES, BACTERIAL; ARTHRALGIA; BORRELIA BURGDORFERI; CEFTRIAXONE; CEPHALOSPORINS; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYME DISEASE;

EID: 0036378066     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.04792.x     Document Type: Article

References (26)

1. Asbrink E, Hovmark A. Early and late cutaneous manifestations in Ixodes-borne borreliosis (erythema migrans borreliosis, Lyme borreliosis). Ann NY Acad Sci 1988; 539: 4-15.
2. Asbrink E, Hovmark A, Hederstedt B. The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer. Acta Derm Venereol (Stockh) 1984; 64: 506-12.
3. Leslie TA, Levell NJ, Cutler SJ et al. Acrodermatitis chronica atrophicans: a case report and review of the literature. Br J Dermatol 1994; 131: 687-93.
4. Luger SW, Krauss E. Serologic tests for Lyme disease. Interlaboratory variability. Arch Intern Med 1990; 150: 761-3.
5. Tugwell P, Dennis DT, Weinstein A et al. Clinical guideline 2: laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med 1997; 127: 1109-23.
6. Brown SL, Hansen SL, Langone JJ. Role of serology in the diagnosis of Lyme disease. JAMA 1999; 282: 62-6.
7. Wormser GP, Aguero-Rosenfeld ME, Nadelman RB. Lyme disease serology: problems and opportunities. JAMA 1999; 282: 79-80.
8. Assous MV, Postic D, Paul G et al. Western blot analysis of sera from Lyme borreliosis patients according to the genomic species of the Borrelia strains used as antigens. Eur J Clin Microbiol Infect Dis 1993; 12: 261-8.
9. Robertson J, Guy E, Andrews N et al. A European multicenter study of immunoblotting in serodiagnosis of Lyme borreliosis. J Clin Microbiol 2000; 38: 2097-102.
10. Nadelman RB, Wormser GP. Lyme borreliosis. Lancet 1998; 352: 557-65.
11. Rosa PA, Hogan D, Schwan TG. Polymerase chain reaction analyses identify two distinct classes of Borrelia burgdorferi. J Clin Microbiol 1991; 29: 524-32.
12. Brehmer-Andersson E, Hovmark A, Asbrink E. Acrodermatitis chronica atrophicans: histopathological findings and clinical correlation in 111 cases. Acta Derm Venereol (Stockh) 1998; 78: 207-13.
13. Asbrink E, Hovmark A, Hederstedt B. Serologic studies of erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans with indirect immunofluorescence and enzyme-linked immunosorbent assays. Acta Derm Venereol (Stockh) 1985; 65: 509-14.
14. Aberer E, Kehldorfer M, Binder B, Schauperl H. The outcome of Lyme borreliosis in children. Wien Klin Wochenschr 1999; 111: 941-4.
15. Muellegger RR, Schluepen EM, Millner MM et al. Acrodermatitis chronica atrophicans in an 11-year-old girl. Br J Dermatol 1996; 135: 609-12.
16. Nadal D, Gundelfinger R, Flueler U, Boltshauser E. Acrodermatitis chronica atrophicans. Arch Dis Child 1998; 63: 72-4.
17. Gellis SE, Stadecker MJ, Steere AC. Spirochetes in atrophic skin lesions accompanied by minimal host response in a child with Lyme disease. J Am Acad Dermatol 1991; 25: 395-7.
18. Menni S, Pistritto R, Piccino R, Trevisan G. Acrodermatitis chronica atrophicans in an Italian child. Acta Derm Venereol (Stockh) 1996; 76: 243 [Letter].
19. Aberer E, Neumann R, Stanek G. Is localized scleroderma a Borrelia infection? Lancet 1985; ii: 278 (Letter).
20. Schempp C, Bocklage H, Lange R et al. Further evidence for Borrelia burgdorferi infection in morphoea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol 1993; 100: 717-20.
21. Wienecke R, Schluepen EM, Zoechling N et al. No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma. J Invest Dermatol 1995; 104: 23-6.
22. Fujiwara H, Fujiwara K, Hashimoto K et al. Detection of Borrelia burgdorferi DNA (B. garinii or B. afzelii) in morphoea and lichen sclerosus et atrophicus tissues of German and Japanese but not of US patients. Arch Dermatol 1997; 133: 41-4.
23. Weide B, Schittek B, Klyscz T et al. Morphoea is neither associated with features of Borrelia burgdorferi infection, nor is this agent detectable in lesional skin by polymerase chain reaction. Br J Dermatol 2000; 143: 780-5.
24. Aberer E, Klade H, Hobisch G. A clinical, histological, and immunohistochemical comparison of acrodermatitis chronica atrophicans and morphoea. Am J Dermatopathol 1991; 13: 334-41.
25. Ramelet AA. Association of acrodermatitis chronica atrophicans and morphoea. Dermatologica 1987; 175: 253-6.
26. Coulson IH, Smith NP, Holden CA. Acrodermatitis chronica atrophicans with coexisting morphoea. Br J Dermatol 1989; 121: 263-9.